Internationally, the prevalence of hepatitis C infection is higher among prisoners when compared to the general population, particularly among people who inject drugs. This study estimates the prevalence of, and compares the risk factors for, hepatitis C in young (< 25 years) and older (≥ 25 years) prisoners with a history of injection drug use. Participants were 677 sentenced prisoners in Queensland, Australia, with a lifetime history of injection drug use, recruited in the 6 weeks prior to release from custody. The prevalence of hepatitis C exposure was significantly lower in young prisoners than in older prisoners (20.7% vs. 29.4%, p = .03). Risk factors for hepatitis C varied between young and older prisoners. Young people who inject drugs and who have had shorter time at risk of hepatitis C exposure are an important target group for hepatitis C prevention efforts.
AbelsonJ., TreloarC., CrawfordJ., KippaxS., Van BeekI., HowardJ. (2006). Some characteristics of early-onset injection drug users prior to and at the time of their first injection. Addiction, 101, 548–555. doi:10.1111/j.1360-0443.2006.01379.x
2.
Australian Government Department of Health and Ageing. (2010). Third National Hepatitis C Strategy 2010–2013 (Pub. No. 6637). Canberra: Commonwealth of Australia.
3.
Australian Institute of Health and Welfare. (2010). The health of Australia’s prisoners 2009. Canberra: Author.
4.
BaldryE., McConnellD., MaplestoneP., PeetersM. (2003). Ex-prisoners and accommodation: What bearing do different forms of housing have on social reintegration?. Melbourne: Australian Housing and Urban Research Institute.
5.
BorzyckiM., BaldryE. (2003). Promoting integration: The provision of prisoner post-release services. Canberra: Australian Institute of Criminology.
6.
BryantJ., BrenerL., HullP., TreloarC. (2010). Needle sharing in regular sexual relationships: An examination of serodicordance, drug using practices, and the gendered character of injecting. Drug and Alcohol Dependence, 107, 182–187.
7.
BryantJ., TreloarC. (2007). The gendered context on initiation to injecting drug use: Evidence for women as active initiates. Drug and Alcohol Review, 26, 287–293.
8.
ButlerT. G., DolanK. A., FersonM. J., McGuinnessL. M., BrownP. R., RobertsonP. W. (1997). Hepatitis B and C in New South Wales prisons: Prevalence and risk factors. Medical Journal of Australia, 166, 127–130.
9.
CalzavaraL., RamuscakN., BurchellA. N., SwanteeC., MyersT., FordP., RaymondS. (2007). Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities. Canadian Medical Association Journal, 177, 257–261.
10.
CarmanM., CorbozJ., DowsettG. W. (2012). Falling through the cracks: The gap between evidence and policy in responding to depression in gay, lesbian and other homosexually active people in Australia. Australian and New Zealand Journal of Public Health, 36, 76–83. doi:10.1111/j.1753-6405.2012.00828.x
11.
CassarJ., StaffordJ., BurnsL. (2009). Examining differences between younger and older injecting drug users in the 2009 National Illicit Drug Reporting System sample. Drug Trends Bulletin, December, pp. 1–5.
12.
Commission for Children and Young People and Child Guardian. (2007). A snapshot 2007: Children and young people in Queensland. Brisbane, Australia: Author.
13.
DantaM., BrownD., BhaganiS., PybusO. G., SabinC. A., NelsonM., DusheikoG. M. (2007). Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS, 21, 983–991. doi:10.1097/QAD.0b013e3281053a0c
14.
DegenhardtL., KinnerS. A., RoxburghA., BlackE., BrunoR., FetherstonJ., FryC. L. (2008). Drug use and risk among regular injecting drug users in Australia: Does age make a difference?. Drug and Alcohol Review, 27, 357–360.
15.
de HertM., CorrellC. U., BobesJ., Cetkovich-BakmasM., CohenD., AsaiI., LeuchtS. (2011). Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry, 10, 52–77.
16.
DiasS., KinnerS., WareR., LennoxN. (2013). Physical health outcomes in prisoners with intellectual disability: A cross-sectional study. Journal of Intellectual Disability Research, 57, 1191–1196.
17.
DolanK., RutterS., WodakA. D. (2003). Prison-based syringe exchange programmes: A review of international research and development. Addiction, 98, 153–158.
18.
DolanK., TeutschS., ScheuerN., LevyM., RawlinsonW., KaldorJ., HaberP. (2010). Incidence and risk for acute hepatitis C infection during imprisonment in Australia. European Journal of Epidemiology, 25, 143–148.
19.
DoyleJ. S., AspinallE., LiewD., ThompsonA. J., HellardM. E. (2013). Current and emerging antiviral treatments for hepatitis C infection. British Journal of Clinical Pharmacology, 75, 931–943. doi:10.1111/j.1365-2125.2012.04419.x
20.
EdlinB. (2002). Prevention and treatment of hepatitis C in injection drug users. Hepatology, 36, S210–S219.
21.
FazelS., BaillargeonJ. (2011). The health of prisoners. Lancet, 377, 956–965. doi:10.1016/S0140-6736(10)61053-7
22.
FetherstonJ., CarruthersS., ButlerT., WilsonD., SindicichN. (2013). Rates of injection in prison in a sample of Australian-injecting drug users. Journal of Substance Use, 18, 65–73. doi:10.3109/14659891.2012.760008
23.
GiddingH. F., AminJ., DoreG. J., WardK., LawM. G. (2010). Hospital-related morbidity in people notified with hepatitis C: A population-based record linkage study in New South Wales, Australia. Journal of Hepatology, 53, 43–49. doi:10.1016/j.jhep.2010.01.036
24.
GouldingD. (2004). Severed connections: An exploration of the impact of imprisonment on women's familial and social connectedness. Perth, Australia: Centre for Social and Community Research, Murdoch University.
25.
HammettT. M., RobertsC., KennedyS. (2001). Health-related issues in prisoner reentry. Crime and Delinquency, 47, 390–409.
26.
HarzkeA. J., BaillargeonJ. G., KelleyM. F., DiamondP. M., GoodmanK. J., PaarD. P. (2009). HCV-related mortality among male prison inmates in Texas, 1994-2003. Annals of Epidemiology, 19, 582–589.
27.
HellardM., DoyleJ. S., Sacks-DavisR., ThompsonA. J., McBrydeE. (2014). Eradication of hepatitis C infection: The importance of targeting people who inject drugs. Hepatology, 59, 366–369. doi:10.1002/hep.26623
28.
HellardM., HockingJ., CroftsN. (2004). The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiology and Infection, 132, 409–415.
29.
HellardM. E., AitkenC. K., HockingJ. S. (2007). Tattooing in prisons—Not such a pretty picture. American Journal of Infection Control, 35, 477–480. doi:10.1016/j.ajic.2006.08.002
30.
IversenJ., WandH., GonnermannA., MaherL. (2010). Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008. International Journal on Drug Policy, 21, 471–476. doi:10.1016/j.drugpo.2010.04.004
31.
JafariS., CopesR., BaharlouS., EtminanM., BuxtonJ. (2010). Tattooing and the risk of transmission of hepatitis C: A systematic review and meta-analysis. International Journal of Infectious Diseases, 14, e928–e940. doi:10.1016/j.ijid.2010.03.019
32.
JinF., PrestageG. P., MatthewsG., ZablotskaI., RawstorneP., KippaxS. C., GrulichA. E. (2010). Prevalence, incidence and risk factors for hepatitis C in homosexual men: Data from two cohorts of HIV-negative and HIV-positive men in Sydney, Australia. Sexually Transmitted Infections, 86, 25–28. doi:10.1136/sti.2009.038182
33.
KinnerS. (2006). Continuity of health impairment and substance misuse among adult prisoners in Queensland, Australia. International Journal of Prisoner Health, 2, 101–113.
34.
KinnerS., JenkinsonR., GouillouM., MilloyM. (2012). High-risk drug-use practices among a large sample of Australian prisoners. Drug and Alcohol Dependence, 126, 156–160. doi:10.1016/j.drugalcdep.2012.05.008
35.
KinnerS. A. (2008). Passports to advantage: Health and capacity building as a basis for social integration. Flinders Journal of Law Reform, 10, 581–589.
36.
KinnerS. A., LennoxN. G., TaylorM. (2009). Randomised controlled trial of a post-release intervention for prisoners with and without an intellectual disability. Journal on Developmental Disabilities, 15, 72–76.
37.
KinnerS. A., MooreE., SpittalM. J., IndigD. (2013). Opiate substitution treatment to reduce in-prison drug injection: A natural experiment. International Journal of Drug Policy, 24, 460–463. doi:10.1016/j.drugpo.2013.01.004
38.
LeaT., MaoL., BathN., PrestageG., ZablotskaI., de WitJ., HoltM. (2013). Injecting drug use among gay and bisexual men in Sydney: Prevalence and associations with sexual risk practices and HIV and hepatitis C infection. AIDS and Behavior, 17, 1344–1351. doi:10.1007/s10461-013-0409-0
39.
LevyM. (2005). Prisoner health care provision: Reflections from Australia. International Journal of Prisoner Health, 1, 65–73.
40.
LinesR. (2006). From equivalence of standards to equivalence of objectives: The entitlement of prisoners to health care standards higher than those outside prisons. International Journal of Prisoner Health, 2, 269–280.
41.
MacalinoG. E., HouJ. C., KumarM. S., TaylorL. E., SumanteraI. G., RichJ. D. (2004). Hepatitis C infection and incarcerated populations. International Journal of Drug Policy, 15, 103–114.
42.
MaherL., ChantK., JalaludinB. I. N., SargentP. (2004). Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia. Journal of Gastroenterology and Hepatology, 19, 1114–1120. doi:10.1111/j.1440-1746.2004.03438.x
43.
MaherL., JalaludinB., ChantK. (2006). Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction, 101, 1499–1508.
44.
MillerE., HellardM., BowdenS., BharadwajM., AikenC. (2009). Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia. Journal of Infection, 58, 375–382.
45.
MillerE. R., BiP., RyanP. (2008). Hepatitis C virus infection in South Australian prisoners: Seroprevalence, seroconversion, and risk factors. International Journal of Infectious Diseases, 13, 201–208.
46.
MistlerL. A., BrunetteM. F., MarshB. J., VidaverR. M., LuckoorR., RosenbergS. D. (2006). Hepatitis C treatment for people with severe mental illness. Psychosomatics, 47, 93–107. doi:10.1176/appi.psy.47.2.93
47.
MorrowK. M., & Project START Study Group. (2009). HIV, STD, and hepatitis risk behaviors of young men before and after incarceration. AIDS Care, 21, 235–243.
48.
National Centre in HIV Epidemiology and Clinical Research. (Ed.). (2009). HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia: 2009 Annual surveillance report. Sydney, Australia: The University of NSW.
49.
PostJ., DolanK., WhybinL., CarterI., HaberP., LloydA. (2001). Acute hepatitis C virus infection in an Australian prison inmate: Tattooing as a possible transmission route. Medical Journal of Australia, 174, 183–184.
50.
Queensland Department of Employment and Training. Office of Youth Affairs. (2002). Queensland Youth Charter: The Queensland Government’s commitment to engaging with young people. Brisbane, Australia: Author.
51.
RobertsA., MathersB., DegenhardtL., On behalf of the Reference Group to the United Nations on HIV and Injecting Drug Use. (2010). Women who inject drugs: A review of the risks, experiences and needs. Sydney, Australia: National Drug and Alcohol Research Centre, University of New South Wales.
52.
SmallW., KainS., SchechterM., O’SchaughnessyM., SpittalP. (2005). Incarceration, addiction and harm reduction: Inmates experience injecting drugs in prison. Substance Use and Misuse, 40, 831–843.
53.
StataCorp. (2009). Stata statistical software: Release 11. College Station, TX: StataCorp LP.
54.
TompkinsC. N., NealeJ., SheardL., WrightN. (2007). Experiences of prison among injecting drug users in England: A qualitative study. International Journal of Prisoner Health, 3, 189–203.
55.
van BeekI., DwyerR., DoreG. J., LuoK., KaldorJ. M. (1998). Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: Retrospective cohort study. British Medical Journal, 317, 433–437.
56.
van DoorenK., KinnerS., ForsythS. (2013). Risk of death for young ex-prisoners in the year following release from adult prison. Australian and New Zealand Journal of Public Health, 37, 377–382.
57.
van DoorenK., RichardsA., LennoxN., KinnerS. (2013). Complex health-related needs among young, soon-to-be-released prisoners. Health and Justice, 1, 1–8. doi:10.1186/2194-7899-1-1
58.
van GemertC., BergeriI., DowningS., HellardM. E., Sacks-DavisR., StooveM. (2010). Evaluation of hepatitis C surveillance in Queensland 2009-2010. Victoria, Australia: Centre for Population Health, Burnet Institute.
